Purchase Order N0017315P1996
- Not listed
- The Office of Naval Research awarded a $16,302 firm fixed-price purchase order to Illumina, Inc. for reagent kits on September 26, 2013, with completion targeted for October 26, 2013. The contract, issued without a set-aside designation, will be performed in San Diego, California. Illumina is a biotechnology company specializing in genetic sequencing and genomic analysis technologies, providing DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software to federal...
- The Office of Naval Research awarded a $5,675.74 firm fixed-price purchase order to Illumina, Inc. for laboratory supplies on May 5, 2017, with an ultimate completion date of August 3, 2017. The contract, issued without a set-aside designation, will be performed in San Diego, California, where Illumina maintains its headquarters. This purchase order represents a routine procurement of laboratory consumables and supplies from the biotechnology company, which specializes in genetic sequencing...
- The Office of Naval Research awarded a $15,000 firm fixed-price purchase order to Illumina, Inc. on July 10, 2014, for the MiSeq Silver Contract, with completion targeted for July 9, 2015. The contract, which carries no set-aside designation, will be performed in San Diego, California. Illumina, a biotechnology company specializing in genetic sequencing and genomic analysis technologies, will deliver products or services supporting the Navy's research initiatives. The MiSeq platform is one of...
- The Office of Naval Research awarded a $15,965 firm fixed-price purchase order to Illumina, Inc. for MiSeq Annual Service on July 10, 2015, with completion scheduled for July 9, 2016. The contract, which did not utilize a set-aside designation, covers maintenance and support services for Illumina's MiSeq DNA sequencing instrument at the contractor's San Diego, California location. Illumina is a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies,...
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. valued at $31,592.90 on August 17, 2017. Place of performance is San Diego, California. The order is for firm fixed-price commercial biotechnology equipment or services, with ultimate completion scheduled for September 15, 2017. No small business set-aside was applied.</p>
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. valued at $15,610.40 for reagent kits, with an award date of September 18, 2012 and ultimate completion date of October 9, 2012. Place of performance is San Diego, California. The order carries firm fixed-price pricing and no set-aside designation.</p>
- This federal contract award was issued by the Office of Naval Research (ONR), a defense agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $23,256.48 firm fixed-price purchase order is for a reagent kit (PR# 69-5525-18) with a completion date of November 26, 2018. The contract does not utilize any set-aside designations. Illumina is a specialized technology provider that has been awarded numerous prime federal contracts and grants...
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. for reagent kits valued at $9,495.20 on July 2, 2019, with completion by August 2, 2019. Place of performance is San Diego, California. The order is firm fixed price with no set-aside designation. No Service Contract Inventory reporting is present in the source.</p>
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a $99,996.96 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for the delivery of Illumina's RNA Prep with Enrichment kits, MiSeq reagent kits, respiratory virus oligo panels, and DNA/RNA universal dual (UD) indexes to support genomic sequencing and analysis requirements at the Naval Health Research Center in San Diego, California....
The Office of Naval Research awarded a $7,422 firm fixed-price purchase order to Illumina, Inc. on June 15, 2015, for Ribo-Zero Magnetic products, with a completion date of July 31, 2015. The contract, executed without a set-aside designation, was performed in San Diego, California, where Illumina maintains its headquarters. Ribo-Zero Magnetic reagents are specialized consumables used in genomic research workflows to deplete ribosomal RNA from samples prior to RNA sequencing, enabling researchers to focus on transcriptomic analysis of expressed genes rather than abundant ribosomal sequences. This purchase order reflects Illumina's established role as a critical supplier of genomic sequencing reagents and consumables to the Department of Defense and broader federal research community. Illumina holds substantial indefinite delivery contract vehicles with multiple agencies, including a $45 million IDIQ with the U.S. Department of Agriculture, and maintains blanket purchase agreements supporting rapid procurement of sequencing technologies across federal laboratories. The modest value of this specific order is characteristic of Illumina's consumables business, where research facilities issue routine replenishment orders for reagent kits that support ongoing genomic analysis operations conducted by Naval Medical Research Command and other ONR-supported laboratories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 6/14/15 |